logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
H

Heather L. McArthur

queen mary university london

43H指数
310论文数
9.9K被引数
收录论文 96
发表时间
logo
OPERA-01: a phase III study of palazestrant for ER+, HER2-advanced breast cancer after CDK4/6 inhibitor therapyOPERA-01: CDK4/6抑制剂治疗后palazestrant治疗ER，HER2-advanced乳腺癌的III期研究
errFUTURE ONCOLOGY
IF2.6
err2026-01-01
err0
PREAI
errPistilli, Barbara; Ezquerra, Meritxell Bellet; Del Mastro, Lucia; Sohn, Joohyuk; Schmid, Peter; Meisel, Jane; Chan, Arlene; Zheng, Lianqing; de Kermadec, Elisabeth; McArthur, Heather
err分享
err收藏
Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trialCapivasertib 联合紫杉醇作为转移性三阴性乳腺癌的一线治疗：来自随机、全球性III期CAPItello-290试验的结果
errAnnals of Oncology
IF65.4
err2025-12-19
err0
PREAI
errP.S. Schmid; H.L. McArthur; J. Cortés; B. Xu; F. Cardoso; M. Casalnuovo; U. Demirci; R. Freitas-Junior; J. Ghosh; R. Hegg; H. Iwata; I. Karnaukhov; Y.L. Chuken; M. Nechaeva; M.E. Robson; R. Villalobos-Valencia; T. Yamashita; B. Zurawski; E.C. de Bruin; L. Grinsted
err分享
err收藏
Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancer乳腺癌患者中，培美曲塞标准间隔给药与延长间隔给药的安全性和临床结局比较
errONCOLOGIST
IF4.2
err2025-12-01
err0
errOAAI
errLeVee, Alexis; Kordic, Austin; Ruel, Nora; Mortimer, Joanne; Kang, Irene; McArthur, Heather; Lechner, Melissa G.; Tsai, Karen
err分享
err收藏
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial出版物简明摘要：比较在CheckMate 7FL临床试验中，对于新诊断的雌激素受体阳性乳腺癌患者，使用纳武利尤单抗联合新辅助化疗与安慰剂联合新辅助化疗的疗效。
errFUTURE ONCOLOGY
IF2.6
err2025-10-01
err0
PREAI
errLoi, Sherene; Salgado, Roberto; Curigliano, Giuseppe; Ivan Romero Diaz, Roberto; Delaloge, Suzette; Rojas Garcia, Carlos Ignacio; Kok, Marleen; Saura, Cristina; Harbeck, Nadia; Mittendorf, Elizabeth A.; Yardley, Denise A.; Suarez Zaizar, Alberto; Caminos, Facundo Rufino; Ungureanu, Andrei; Reinoso-Toledo, Joaquin G.; Guarneri, Valentina; Egle, Daniel; Ades, Felipe; Pacius, Misena; Chhibber, Aparna; Chandra, Rajalakshmi; Nathani, Raheel; Spires, Thomas; Qun Wu, Jenny; Pusztai, Lajos; Mcarthur, Heather
err分享
err收藏
A comprehensive evaluation of de novo metastatic breast cancer trends by subtype from the Dallas Metastatic Cancer Study德克萨斯州转移性癌症研究对原发肿瘤转移性乳腺癌不同亚型趋势的全面评估
errCommunications Medicine
IF6.3
err2025-08-05
err0
errOAAI
errHannah L. Chang; Meng Cao; Mir Lim; Anna Moscowitz; Ang Gao; Ariana Weiss; Ariel Brown; Danielle Spanbauer; Giselle Uwera; Jaeyoung Oh; Jonathan Ladner; Nathaniel Wu; Priscilla Okanlawon; Reynaldo Olivo; Ruchita Iyer; Yemariamwork Engidaw; Sangeetha M. Reddy; Heather L. McArthur; Lily Xu; Sakshi Mohta; Julia Maues; Christine Hodgdon; Luis Chinea; Katherine Lei; Shao-Po Huang; Rani Bansal; Isaac S. Chan
err分享
err收藏
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophages作者更正：分泌IL-17A的γδ T细胞通过CX3CR1+巨噬细胞促进HR+HER2−乳腺癌对CDK4/CDK6抑制剂的抵抗
errNature Cancer
IF28.5
err2025-07-23
err0
PREAI
errGiulia Petroni; Claudia Galassi; Kenneth H. Gouin; Hsiang-Han Chen; Aitziber Buqué; Norma Bloy; Takahiro Yamazaki; Ai Sato; Manuel Beltrán-Visiedo; Ginevra Campia; Carlos Jiménez-Cortegana; Aagam Shah; Alexander Kirchmair; Chiara Massa; Claudia Wickenhauser; Carlos Eduardo de Andrea; Belén Navarro-Rubio; Irantzu Serrano-Mendioroz; Esther Navarro Manzano; Alexandra M. Satty; Brady Rippon; Francesca Finotello; Zlatko Trajanoski; Xi Kathy Zhou; Joseph M. Scandura; Elena García-Martínez; Francisco Ayala de la Peña; María Esperanza Rodríguez-Ruiz; Barbara Seliger; Víctor Sánchez-Margalet; Luis de la Cruz-Merino; Reva K. Basho; Stephen L. Shiao; Heather L. McArthur; Silvia C. Formenti; Simon R. V. Knott; Lorenzo Galluzzi
err分享
err收藏
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2− breast cancer via CX3CR1+ macrophagesIL-17A分泌型γδ T细胞通过CX3CR1+巨噬细胞促进HR+HER2−乳腺癌对CDK4/CDK6抑制剂的抵抗
errNature Cancer
IF28.5
err2025-07-07
err0
PREAI
errGiulia Petroni; Claudia Galassi; Kenneth H. Gouin; Hsiang-Han Chen; Aitziber Buqué; Norma Bloy; Takahiro Yamazaki; Ai Sato; Manuel Beltrán-Visiedo; Ginevra Campia; Carlos Jiménez-Cortegana; Aagam Shah; Alexander Kirchmair; Chiara Massa; Claudia Wickenhauser; Carlos Eduardo de Andrea; Belén Navarro-Rubio; Irantzu Serrano-Mendioroz; Esther Navarro Manzano; Alexandra M. Satty; Brady Rippon; Francesca Finotello; Zlatko Trajanoski; Xi Kathy Zhou; Joseph M. Scandura; Elena García-Martínez; Francisco Ayala de la Peña; María Esperanza Rodríguez-Ruiz; Barbara Seliger; Víctor Sánchez-Margalet; Luis de la Cruz-Merino; Reva K. Basho; Stephen L. Shiao; Heather L. McArthur; Silvia C. Formenti; Simon R. V. Knott; Lorenzo Galluzzi
err分享
err收藏
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium乳腺癌管理中的争议与关键知识空白专家观点：第一届弥合乳腺癌知识空白研讨会的会议录
errClinical Breast Cancer
IF2.5
err2025-04-08
err0
PREAI
errKomal Jhaveri; Carey K. Anders; Aditya Bardia; Manali Bhave; A. Jo Chien; Ian Krop; Tiffany A. Traina; Yara Abdou; Reva Basho; Alison K. Conlin; Francisco J. Esteva; Kevin R. Fox; Vijayakrishna Gadi; Peter A. Kaufman; Anya Litvak; Cynthia X. Ma; Eleftherios P. Mamounas; Heather McArthur; Kelly McCann; Zahi Mitri; Rebecca Shatsky; Melinda Telli; Mylin A. Torres; Kevin Kalinsky
err分享
err收藏
ASO Visual Abstract: Factors Associated with Nodal Positivity Following Neoadjuvant Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2025-03-01
err0
PREAI
errOzcan, B. Bersu; Arjmandi, Firouzeh K.; Polat, Dogan S.; Xi, Yin; Sahoo, Sunati; Leitch, Marilyn; Mcarthur, Heather; Dogan, Basak E.
err分享
err收藏
Factors Associated with Nodal Positivity Following Neoadjuvant Systemic Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2025-02-13
err1
PREAI
errOzcan, B. Bersu; Arjmandi, Firouzeh K.; Polat, Dogan S.; Xi, Yin; Sahoo, Sunati; Leitch, Marilyn; Mcarthur, Heather; Dogan, Basak E.
err分享
err收藏
TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2-breast cancerTROPION-Breast04：一项针对治疗初治早期三阴性或HR低表达/HER2阳性乳腺癌患者的新辅助达托妥单抗德鲁替康（Dato-DXd）联合度伐利尤单抗，随后进行辅助度伐利尤单抗与标准护理对照的随机III期研究
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2025-02-05
err1
errOAAI
errHeather L. McArthur; Sara M. Tolaney; Rebecca Dent; Peter Schmid; Jamil Asselah; Qiang Liu; Jane Lowe Meisel; Naoki Niikura; Yeon Hee Park; Gustavo Werutsky; Giampaolo Bianchini; Jay C. Andersen; Robert Kozarski; Nana Rokutanda; Barbara Pistilli; Sibylle Loibl
err分享
err收藏
Can time to surgery or size of tumor predict pathologic complete response (pCR) for early stage hormone receptor positive (HR+) (HER2-) breast cancer on a preoperative ablative S-PBI phase I trial手术时间或肿瘤大小能否预测在术前消融S-PBI I期试验中，早期激素受体阳性(HR+)、人表皮生长因子受体2阴性(HER2-)乳腺癌的病理完全缓解(pCR)？
errBREAST
IF7.9
err2025-02-01
err0
errOAAI
errRahimi, A.; Leitch, M.; Dogan, B.; Liu, Y. -l.; Alluri, P.; Arbab, M.; Li, X.; Parsons, D.; Wandrey, N.; Farr, D.; Seiler, S.; Unni, N.; Nguyen, A.; Wooldridge, R.; Lu, W.; Stojadinovic, S.; Bahrami, S.; Stein, M.; Mcarthur, H.; Sahoo, S.; Timmerman, R.
err分享
err收藏
Capivasertib (C) plus paclitaxel (P) as first-line treatment of metastatic triple-negative breast cancer (mTNBC): The CAPItello-290 phase III trialCapivasertib (C)联合多西他赛（P）作为转移性三阴性乳腺癌（mTNBC）的一线治疗方案：CAPItello-290 III期试验
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err2
PREAI
errSchmid, P.; McArthur, H. L.; Cortes, J.; Xu, B.; Cardoso, F.; Casalnuovo, M. L.; Demirci, U.; Freitas, R., Jr.; Ghosh, J.; Hegg, R.; Iwata, H.; Chuken, Y. A. Lopez; Nechaeva, M.; Robson, M. E.; Villalobos Valencia, R.; Lloyd, A.; D'Cruz, C.; Foxley, A.; Park, Y. H.
err分享
err收藏
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice (June, 10.1007/s10549-024-07427-2, 2024)
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2024-07-13
err0
errOAAI
errBhave, Manali A.; Quintanilha, Julia C. F.; Tukachinsky, Hanna; Li, Gerald; Scott, Takara; Ross, Jeffrey S.; Pasquina, Lincoln; Huang, Richard S. P.; McArthur, Heather; Levy, Mia A.; Graf, Ryon P.; Kalinsky, Kevin
err分享
err收藏
Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2024-06-24
err3
errOAAI
errDent, Rebecca; Cortes, Javier; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Fasching, Peter A.; Cardoso, Fatima; Haiderali, Amin; Jia, Liyi; Nguyen, Allison Martin; Pan, Wilbur; O'Shaughnessy, Joyce; Schmid, Peter
err分享
err收藏
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2024-06-14
err1
errOAAI
errBhave, Manali A.; Quintanilha, Julia C. F.; Tukachinsky, Hanna; Li, Gerald; Scott, Takara; Ross, Jeffrey S.; Pasquina, Lincoln; Huang, Richard S. P.; Mcarthur, Heather; Levy, Mia A.; Graf, Ryon P.; Kalinsky, Kevin
err分享
err收藏
Contemporary HER2-Positive MBC Treatment Recommendations Among Community Healthcare Professionals: Analysis of an Online Interactive Decision Support Tool
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errRosenthal, Kristen; Hurvitz, Sara; Jhaveri, Komal; McArthur, Heather; Tolaney, Sara; Quill, Timothy
err分享
err收藏
Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for early-stage triple-negative breast cancer: Updated event-free survival results from the phase 3 KEYNOTE-522 study
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errSchmid, Peter; Cortes, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Foukakis, Theodoros; Mouret-Reynier, Marie-Ange; Ferreira, Marta; Im, Seock-Ah; Cardoso, Fatima; Ding, Yu; Pan, Wilbur; Tryfonidis, Konstantinos; O'Shaughnessy, Joyce
err分享
err收藏
Neoadjuvant HER2-targeted Therapy plus /Immunotherapy with Pembrolizumab (neoHIP): An Open Label Randomized Phase II Trial
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errMcArthur, Heather; Leal, Jorge Henrique Santos; Chan, Isaac; Unni, Nisha; Shiao, Stephen; Gruber, Joshua; Syed, Samira; Peswani, Namrata; Sadeghi, Navid; Delgado, Glenda; Klemow, Dawn; Basho, Reva; Carter, Meredith; Badran, Mai; Qureshi, Nasir; Curtin, Jessica; Weese, Joshua; Rice, Stephanie; Phillips, Michelle; Chan, David; Hool, Hugo; Park, Dorothy; El-Masry, Mary; McAndrew, Philomena; Sikaria, Swati; Spring, Laura; Bardia, Aditya; Tighiouart, Mourad; Dadmanesh, Farnaz; Giuliano, Armando; Sanchez, Katherine; Page, David
err分享
err收藏
Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errRahimi, Asal; Leitch, A. Marilyn; Dogan, Ba. Ak; Alluri, Prasanna; Farr, Deborah; Arbab, Mona; Seiler, Stephen; Kim, Nathan; Wooldridge, Rachel; Unni, Nisha; Nwachukwu, Chika; Patel, Ina; Zhang, You; Parsons, David; Nguyen, Anvy; Morgan, Howard E.; McArthur, Heather; Sahoo, Sunati; Timmerman, Robert
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jedd D. Wolchok
H 指数: 173 · 论文数: 1.4K
G
Giuseppe Viale
H 指数: 157 · 论文数: 1.3K
J
James P. Allison
H 指数: 157 · 论文数: 1.2K
M
Martine Piccart
H 指数: 149 · 论文数: 1.6K
F
Fabrice André
H 指数: 148 · 论文数: 1.8K
查看更多